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Abstract:  Aflatoxin  B1  is  a  common  contaminant  of  poultry  feeds  in  tropical  and 
subtropical  climates.  Research  during  the  last  five  decades  has  well  established  the 
negative effects of the mycotoxin on health of poultry. However, the last ten years of 
relevant data have accentuated the potential of low levels of aflatoxin B1 to deteriorate 
broiler  performance.  In  this  regard,  any  attempt  to  establish  a  dose-effect  relationship 
between aflatoxin B1 level and broiler performance is also complicated due to differences 
in types of broilers and length of exposure to the mycotoxin in different studies. Contrary 
to  the  prevalent  notion  regarding  literature  saturation  with  respect  to  aflatoxicosis  of 
chicken, many areas of aflatoxicosis still need to be explored. Literature regarding effects 
of  the  mycotoxin  on  the  gastrointestinal  tract  in  this  regard  is  particular  scanty  and  
non-conclusive. In addition to these issues, the metabolism of aflatoxin B1 and recently 
proposed  hypotheses  regarding  biphasic  effects  of  the  mycotoxin  in  broilers  are 
briefly discussed. 
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1. Introduction 
Aflatoxins,  secondary  metabolites  of  various  Aspergillus  spp.,  commonly  contaminate  a  wide 
variety  of  tropical  and  subtropical  food/feed  stuffs.  These  mycotoxins  are  known  to  have  strong 
hepatotoxic and carcinogenic effects and are regulated by feed/food law in at least 100 countries [1]. 
Chemically, aflatoxins are difuranocoumarin compounds and include B1, B2, G1, G2, M1, and M2 [2] 
(Figure 1). These mycotoxins contaminate a wide variety of agricultural commodities including oilseed 
meals, dried fruits, spices, and cereals [3]. Aflatoxins M1 and M2 however, mainly occur in milk 
(AFM1 in small quantities also reported in eggs) as metabolites of the B1 and B2. Among the various 
types of aflatoxins, aflatoxin B1 (AFB1) is most commonly encountered and it is also considered to 
have higher toxicity than other aflatoxins. 
Figure 1. Structure of aflatoxins. 
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The discovery and isolation of aflatoxins is well known to be a result of investigations on the 
mysterious Turkey-X disease of 1960 which resulted in loss of several thousand turkey poults in the 
United Kingdom. The cause of enormous mortality in turkey poults and of similar outbreaks in other 
farm animals could be linked with the use of moldy Brazilian peanut meal in the diet of affected 
animals  [4].  The  suspected  toxic  factor  was  found  to  be  extractable  by  using  chloroform  [5].  Its Toxins 2011, 3                                       
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association with Aspergillus flavus could then be established in the year 1961 [6]. In 1962, the name 
―aflatoxin‖, using first letter from ―Aspergillus‖ and the first 3 letters from ―flavus‖ was proposed [7]. 
Aflatoxin was in the same year isolated in crystalline form in the Netherlands [8], and separated into 
two components, B and G in the United Kingdom [9]. This was followed by a further division of the 
aflatoxin B into B1 and B2 and later their chemical characterization by Asao et al. [10]. Details of these 
landmarks and other studies have been reported in earlier reviews [7,11]. 
Since the discovery of aflatoxins, their negative effects on animal health have been an active area of 
research. In this regard, research during the last five decades has well elucidated the negative effects of 
aflatoxins on animal performance and immunity. To date, various aspects of the aflatoxicosis in farm 
animals  including  effects  on  animal  performance  and  metabolism,  metabolism  of  the  toxin,  and 
carryover  of  toxic  residues  to  animal  products  have  been  the  subjects  of  several  comprehensive  
reviews  [12].  However,  some  aspects  of  aflatoxicosis,  particularly  effects  on  gastrointestinal  
tract (GIT), are not well documented. The present review therefore intends to encompass these areas of 
aflatoxicosis in broilers. Furthermore, contemporary issues regarding dose-effect relationship between 
dietary levels of AFB1 and broiler performance [13], and recently proposed biphasic effects of the 
toxin  on  broiler’s  weight  gain  [14]  are  discussed.  The  latter  hypothesis  regarding  aflatoxicosis  is 
extended to other variables of broiler health wherever sufficient data are available. 
2. Metabolism of Aflatoxin B1 
Relative sensitivity of various animal species to AFB1 has been presented in Table 1. The sensitivity 
of chicken is comparative to that of rats, and both species appear to be insensitive on a comparative 
scale. The difference regarding sensitivity of various animal species towards AFB1 is thought to be 
linked with  differential  state of the  toxin’s metabolism and  the types  of metabolites formed  [15]. 
However, many aspects of metabolism of AFB1 in chickens need to be investigated. 
Table 1. Comparison of LD50 and acute effects of AFB1 on liver of various animal species 
1. 
Species  LD50
 
Lesions in Liver 
Necrosis and 
Hemorrhage 
Fibrosis 
Regeneration 
of Nodules 
Bile Duct 
Proliferation
/Hyperplasia 
Vacuolation 
and Fatty 
Infiltration 
Enlarged 
Hepatic 
Cells 
Rabbit  0.4  +  -  +  +  -  + 
Duckling  2.8  +  -  +  +  +  + 
Pig  3.9  +  +  +  +  +  + 
Dog  6.3  +  +  +  +  +  + 
Guinea pig  10.6  +  -  +  +  +  + 
Sheep 
2  12.5             
Mouse  56.3  -  -  -  -  +  + 
Chicken  72.0  -  -  -  +  +  + 
Rat  73.3  +  -  +  +  +  + 
1 Modified from Patterson [7], with data on chicken from Miazzo et al. [16], and Denli et al. [17]. 
LD50  in  mg/kg  body  weight. 
2 Data  not  available,  however  metabolism  of  AFB1  is  slower  in 
sheep [15]. Sufficient data indicate reduced weight of liver [18], and hepatic carcinoma [19] in 
sheep. Abbrev.: + noted effects; - effects not noted; empty cells indicate lack of data. Toxins 2011, 3                                       
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2.1. Absorption and Excretion 
Work done utilizing murine models indicate that absorption of aflatoxins is a very fast process that 
follows first order kinetics [20,21]. Approximately all of the orally administered AFB1 has been noted 
to be absorbed in rats [22,23]. Absorption is followed by an extensive transformation into metabolites 
primarily in liver [24]. However, the elimination of aflatoxins from body is slower as compared to the 
case of other mycotoxins especially trichothecenes. Wong and Hsieh [25] investigated the excretion of 
14C-labelled AFB1 in mice, rats, and monkeys. These authors found the excretion of AFB1 to be high 
during initial 24 h of the i.v. injection. However, the total recovery of the administered AFB1 was 
between 72 and 80% during the first 100 h after the i.v. injection. In case of laying hens, 71% of the 
14C-labelled AFB1 administered into crop could be recovered within 7 days post-administration [26]. 
In this study, only 28% of the administered dose of AFB1 could be recovered during first 24 h. On day 
1,  4,  and  7  of  post-administration  of 
14C-labelled  AFB1,  the  accumulation  of  radioactivity  was 
estimated by these authors to be 1.3, 1, and 1.1% of the total administered dose. Liver and reproductive 
organs were found to be the main sites for accumulation of radioactivity. In a contemporary study, 
Mabee and Chipley [27] investigated the metabolism of AFB1 during continuous exposure. These 
authors administered 
14C-labelled AFB1 to laying hen by using crop intubation tube for 14 consecutive 
days. At 5 h post-intubation of the last dose, the total radioactivity in hens was approximately equal to 
the daily dose of the toxin. It was therefore concluded that most of the 
14C-labelled AFB1 administered 
during first 13 days was excreted before administration of the final dose on 14th day—providing a clue 
that elimination AFB1 is faster during continuous exposure. Wolzak et al. [28] have reported that tissue 
residues of aflatoxins were highest in kidney, gizzard, and liver (average conc. 3 μg/kg mass) when 
broilers were exposed for 4 weeks to a mixture of AFB1 and AFB2. After 7 days of removal of the 
contaminated feed, aflatoxin residues could not be detected in aforementioned tissues. In this regard, a 
recent study by Hussain et al. also indicates that the elimination of AFB1 in chicken increase during 
longer exposure to AFB1 [29]. These authors fed broiler chicks on rations containing 0, 1.6, 3.2, and 
6.4 µg AFB1/kg for 7, 14, or 28 days age. After 2 to 3 days of exposure, AFB1 could be detected in 
livers of the birds exposed to 1.6 µg AFB1/kg and higher dietary levels of the toxin. After cessation of 
toxin feeding, AFB1 residues decreased in livers and muscles of all the birds, with lower levels at  
10 days post-cessation in the birds exposed to higher toxin levels. These authors concluded that the 
residues of AFB1 in tissues increase with increase in dietary concentration of the toxin but decrease 
with increase in age (or after longer exposure) of broiler chicks. The elimination of AFB1 from tissues 
was rapid in older birds than in younger birds. 
2.2. Metabolism 
Besides being the primary organ of AFB1 accumulation and metabolism, liver is also the main site 
where AFB1 is metabolized and where the metabolites bind with nucleic acids and proteins. Kidneys also 
take part in detoxification of aflatoxins and are also among the organs where most of the aflatoxin 
residues are detected [26,30]. The metabolism of AFB1 after absorption has been previously reviewed in 
detail [7,24,31–35]. In summary, cytochrome P450 enzymes (CYP) (including CYP1A2, CYP3A4 and 
CYP2A6)  in  the  liver  and  other  tissues  convert  AFB1  to  epoxides  (AFB1-8,9-exo-epoxide,  and  Toxins 2011, 3                                       
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AFB1-8,9-endo-epoxide), and to AFM1, AFP1, AFQ1, and its reduced form aflatoxicol (Figure 2). Of 
the  epoxides,  the  AFB1-8,9-exo-epoxide  (and  not  the  AFB1-8,9-endo-epoxide)  can  form  covalent 
bonds with DNA and serum albumin resulting in AFB1-N7-guanine and lysine adducts, respectively. 
Like AFB1, AFM1 can also be activated to form AFM1-8,9-epoxide that binds to DNA resulting in 
AFM1-N7-guanine adducts. These guanine and lysine adducts have been noted to appear in urine. The 
metabolites AFP1, AFQ1, and aflatoxicol are thought to be inactive and are excreted as such in urine, 
or in the form of glucuronyl conjugates from bile in feces. 
In case of chicken exposed to AFB1 contaminated rations, AFB1, AFM1, and aflatoxicol have been 
detected in liver, kidneys, and thigh muscles [36]. Besides these, AFB2a has also been detected in livers 
of both broilers and layers on a ration contaminated with a mixture of aflatoxins (AFB1 80%; AFB2 
2.6%; AFG1 16.8%; and AFG2 0.1%) [30]. Recent studies have shown that CYP2A6 and to a lesser 
extent YP1A1 are responsible for bio-activation of AFB1 into epoxide form in the liver of chicken and 
quail [37]. More data are however needed to fully understand the differences in metabolism of chicken 
with species which are comparatively more sensitive to AFB1. 
Figure  2.  Mechanisms  of  AFB1  toxicity  [32].  In  the  endoplasmic  reticulum,  AFB1  is 
converted to hydroxylated metabolites (via monooxygenases) which are then metabolized to 
glucuronide and sulfate conjugates. An alternate pathway is the oxidation of AFB1 to form 
AFB1-8,9-epoxide  which  can  further  undergo  hydrolysis  to  form  AFB1-8,9-dihydrodial.  
The  epoxide  can  also  be  conjugated  (to  form  GSH-conjugate)  and  thus  detoxified  by 
glutathione S-transferases. 
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3. Effects of Aflatoxin B1 on Performance and Serum Chemistry 
Various  reports  on  effects  of  aflatoxins  on  bird  performance  and  serum  chemistry  have  been 
previously reviewed by Patterson [7], Dersjant-Li et al. [13], and Devegowda and Murthy [38]. There 
is  a  general  agreement  that  dietary  aflatoxins  reduce  weight  gain,  feed  intake,  and  increase  feed 
conversion ratio. Information from the aforementioned reviews and some recent studies is summarized 
in Table 2. These data indicate that AFB1 has the capability to reduce broiler performance and increase 
the incidence of bruising in carcass when present at levels of more than 0.5 mg/kg diet. Dersjant-Li et al. 
in this regard concluded in their review that each mg of AFB1/kg diet would decrease the growth 
performance of broilers by 5% [13]. However, data published during last decade regarding effect of 
low doses of AFB1 on weight gain is not consistent with this generalization. For instance, Raju and 
Devegowda  [39]  noted  21%  decrease  in  final  body  weight  at  35  days  age  in  broilers  fed  on  
0.3 mg AFB1/kg diet. Contrary to this, Tedesco et al. [40] noted only 10% reduction in weight gain of 
broilers at 28 days of exposure to 0.8 mg AFB1/kg diet. For levels of AFB1 of 1 mg/kg diet, 10% 
reduction in weight gain was noted by Zhao et al. [41] at 21 days of exposure while 15% reduction at  
42 days exposure was noted by Denli et al. [17]. At further higher levels of 3 mg AFB1/kg diet, only 
11%  reduction  in  weight  gain  at  21  days  exposure  was  noted  by  Valdivia  et  al.  [42].  Similarly,  
Miazzo et al. [16] found 11% reduction in weight gain when 2.5 mg AFB1/kg diet was fed to broilers 
from 21 to 42 days of age. From these reports, it is evident that both the level and length of AFB1 
exposure affect the amount of reduction in weight gain of broilers. Furthermore, different type of and 
rations  used  in  different  studies  make  it  impractical  to  generalize  the  dose-response  relationship 
regarding weight gain. 
Table 2. Summary of effects of AFB1 on gross performance variables in chicken. 
AFB1 
(mg/kg) 
Performance  
*
,1,2,4 
Bruising 
3 
Weight of Organs    Serum 
1,3,4 
Liver 
1,4  Spleen 
1,4 
Bursa and 
Thymus 
5 
  Lipid  Protein 
≤0.1  ~    ~        ~  ~ 
0.5  ↓  ~  ~        ~  ~ 
1.0  ↓  ↑  ↑    ↓    ↓  ↓ 
2.5  ↓  ↑  ↑  ↑  ↓    ↓  ↓ 
≥5.0  ↓  ↑  ↑  ↑      ↓  ↓ 
* Bird performance variables include body weight gain, feed consumption. Abbrev.: empty cells 
indicate  lack  of  effect;  ~  indicates  inconsistent  data;  ↑  indicate  increase;  ↓  indicate  decrease;  
? indicates lack of data; enzyme activity in terms of lysosomal enzyme activity; TP, total protein; 
wt., weight. 
1 [7]; 
2 [13]; 
3 [38]; 
4 [16–17,39–48]; 
5 [49,50]. 
It is interesting to mention that many authors who reviewed the studies conducted prior to the 1980s 
considered 1.25 mg AFB1/kg diet as not having any negative effects on broiler performance [7]. Recent 
literature, as briefly reviewed in the preceding paragraph, on the other hand documents negative effects 
of lower levels of the toxin on broiler performance. Even the levels of AFB1 as low as 0.02 mg/kg diet 
have  been  indicated  to  decrease  weight  gain  of  broilers  by  5%  (P  <  0.05)  in  a  3  weeks  feeding 
study [48]. One explanation of these differences in earlier and recent reports could be the difference in Toxins 2011, 3                                       
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the performance of broilers available at the time of study. Modern broiler in this connection is known 
to gain more weight by utilizing less feed in shorter time [51–53]. As AFB1 is known as hepatotoxic, it 
might  result  in  more  profound  negative  effects  in  birds  with  more  efficient  nutrient  conversion 
demanding faster hepatic metabolism. Differences in the susceptibility of broilers and layers in this 
regard have been already postulated to be due to differences in metabolic rate of these bird types. Yet 
another possible cause of these differences could be sensitivity of analytical methods available at the 
time of previous and present studies. 
In a recent review, Diaz et al. proposed that the effects of AFB1 on weight gain in broilers could be 
of biphasic nature (hormesis), i.e., improvement at low doses while reduction at high doses [14]. In the 
review of Diaz et al., the maximum improvement in weight gain of broilers was stated to be 3 to 4% 
during exposure to low levels of AFB1. In the aforementioned report of Tedesco et al. [40] these 
authors however noted 13% improvement in weight gain of broilers during 2nd week of exposure to  
0.8 mg AFB1/kg diet. After 2nd week of exposure the weight gain of broilers started to decline under 
AFB1 diet with statistically significant effects apparent during 4th week of exposure. It therefore seems 
that  the  length  of  exposure  to  AFB1  besides  its  level  could  also  influence  the  type  of  response 
regarding weight gain. However these improvements in weight gain, though might be of economic 
importance, were never reported to be of any statistical significance. 
Studies conducted during last decade on effects of AFB1 on serum chemistry are summarized in 
Table 3. From the presented data, it is apparent that AFB1 at levels of up to 0.3 mg/kg decreases serum 
cholesterol levels. As the dietary level of AFB1 increases to 1 mg/kg, total serum protein and albumin 
contents  are  decreased.  At  further  higher  levels  of  2  mg/kg  diet,  lower  serum  glucose,  Ca,  and 
inorganic P levels are recorded. Though Raju and Devegowda [39] reported lower total serum protein 
in broilers exposed to 0.3 mg AFB1/kg diet, several other authors including Tedesco et al. [40] could 
not note any effects of higher doses of AFB1 on this variable. From the presented data, it is also not 
possible to draw a dose-effect relationship for levels of serum enzymes including alkaline phosphatase, 
alanine  transferase,  γ-glutamyl  transferase.  However,  altered  concentrations  of  these  enzymes  are 
usually noted at 1 mg AFB1/kg diet. Besides these effects, AFB1 is also known to induce glutathione 
depletion and result in lipid peroxidation [54]. 
Table 3. Effect of AFB1 on hematology and serum chemistry, as noted in recent studies. 
AFB1 Level (ppm) 
Bird Type, and Age 
(days) 
n * 
Hematology and Serum Chemistry  Year of 
Study and 
Reference 
Effects  No Effects 
0, 0.1 
♂Ross308, 427–457  
4 
(12) 
↓ AP  AST, γ-GT, TP, Chl, BUN, creatinine  2010 [55] 
0, 0.3 
Broilers, 1–35  
12 
↓ TP and Chl at 21 days 
↓ TP, Chl, γ-GT, AST at 35 days 
BUN, ALT, γ-GT, AST at 21 days. 
BUN, ALT, Hb at 35 days 
2000 [39] 
0, 0.8 
♂Broilers, 14–49  
7  ↓ ALT 
TP, albumin, globulin, Glc., AST, γ-
GT, Ca, P 
2004 [40] 
0, 1.0 
♂Cobb, 1–21  
4 
(8) 
↓ TP, albumin, Chl, Ca  Uric acid, γ-GT, P  2008 [47] 
0, 1.0 
♂Ross308, 1–42  
10  ↑ AP 
TP, albumin, AST, γ-GT, uric acid, 
Chl, triglyceride 
2009 [17] Toxins 2011, 3                                       
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Table 3. Cont. 
AFB1 Level (ppm) 
Bird Type, and 
Age (days) 
n * 
Hematology and Serum Chemistry 
Year of Study 
and Reference  Effects  No Effects 
0, 1.0 
broilers, 1–21  
5 
(15) 
↓ TP, albumin, globulin 
BUN, Glc., AP, AST, γ-GT, CK, 
Na, K, Cl, Ca, P 
2010 [41] 
0, 2 
broilers, 1–21 
5 
(15) 
↓ TP, albumin, globulin,  
AP, Glc, Ca, P 
BUN, AST, γ-GT, CK,  
uric acid, Na, K, Cl 
2010 [41] 
0, 3 
Hubb, 1–21 
20 
↓ TP, ALT 
↑ AST 
-  2001 [42] 
0, 3.5 
broilers, 1–21 
6 
(18) 
↓ TP, albumin, Chl, creatinine, Ca, 
MCV 
AP, ALT, P, RBC, MCH, MCHC  1997 [45] 
0, 4 
♂PetxHubb, 1–21  
6 
(12) 
↓ TP, BUN, Chl, PMCV, hematocrit 
% 
-  1997 [43] 
0, 4 
♂broilers, 1–21  
5 
(15) 
↓ TP, albumin, globulin, Chl, Glc., 
Ca, P 
↑ Na, Cl 
-  1998 [46] 
0, 5 
AAxPet, 1–21  
6 
(12) 
↓ TP, albumin, Chl, uric acid, AP, 
Ca. 
↑ CK 
P  1998 [56] 
0, 5 
broilers, 1–21  
6 
(12) 
↓ TP, albumin, Chl 
↑ BUN, CK 
-  1998 [45] 
* Number of replicates. The figure in parenthesis indicates number of animals per replicate. Abbrev.: AA, Arbor Acres; 
ALT, alanine transferase; AP, alkaline phosphatase; AST, aspartate amino transferase; BUN, blood urea nitrogen; Chl, 
cholesterol; CK, creatinine kinase; conc., concentration; Glc, glucose; Hb, hemoglobin; Hubb, Hubbard; Pet, Peterson; 
MCV,  mean  corpuscular  volume;  MCH,  mean  corpuscular  hemoglobin;  MCHC,  mean  corpuscular  hemoglobin 
concentration; RBC, red blood cell; γ-GT, γ-glutamyl transferase. 
4. Effects of Aflatoxin B1 on Adaptive Immunity 
Secondary to the effects on liver, the immunosupressive nature of AFB1 is the best documented area 
of  its  toxicity.  Recent  epidemiological  data  also  indicate  high  correlation  between  outbreaks  of 
Newcastle disease (ND) and aflatoxin contamination of broiler rations [57,58]. 
Generally, the immunotoxic dose of AFB1 is considered as less than the dose required eliciting a 
reduction in bird performance. Selected studies on the effects of AFB1 on response from vaccines 
(humoral  immunity),  and  cell  mediated  immunity  are  presented  in  Table  4.  Though  several 
contradictory reports are available, the threshold dose of AFB1 may be generalized to be 0.4 and  
1 mg/kg for the negative effects on cell mediated and humoral immunity, respectively. However, the 
question  regarding  susceptibility  of  modern  broiler  regarding  immunotoxicity  remains  yet  to  be 
answered. Furthermore, there is evidence regarding biphasic nature of the effects of AFB1 on humoral 
immunity.  In  this  regard  our  recent  data  (Table  5)  indicate  that  humoral  immune  response  from 
broilers could increase and decrease depending upon the level and length of exposure to the toxin.  Toxins 2011, 3                                       
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Table 4. Effects of AFB1 on humoral and cell mediated immunity in chicken. 
AFB1 Level (ppm) 
Bird Type, Age (days) 
Vaccine 
Age 
Effects  No Effects 
Year of Study 
and Reference 
Humoral immunity:       
0.1, 0.2, 0.4, 0.5, 1.0 
Broiler, 14–49  
?  - 
Titers to ND and  
fowl cholera 
1985 [59] 
0.1, 0.2, 0.4, 0.8 
broiler, 14–49  
?  - 
Titers to ND and  
fowl cholera 
1985 [60] 
1 (AF) 
Broiler, 7–49 
14 days 
↓ ND titers at 1 and 3 
weeks post vaccination 
ND titers at 2, 4, and 5 
weeks post vaccination 
2003 [61] 
2.5 (AF) 
Faobro, 1–21 
7 + 21 
days 
↓ ND titers at 28 days 
age 
-  2000 [62] 
0, 0.6, 1.2, 2.5 
Broiler, 1–42 
- 
↓ total complement 
activity at 2.5 ppm 
total complement 
activity at 0.6 and  
1.2 ppm 
1985 [63] 
5 
Broiler, 1–35  
1 + 21 
days  
↑ secondary antibodies 
against IBD at 28 and 
35 days 
-  1997 [64] 
0.2 
♀Leghorn,  
126–280 
? 
↓ antibody titers to ND, 
IB, and IBD 
-  1998 [65] 
2.5 
♂Leghorn, 1–28 
21 days  - 
ND, IB titers; at 35 
days susceptibility to 
ND 
1978 [66] 
2.5 
♂Leghorn, 1–49 
21 days  - 
ND titers; 
susceptibility to ND  
at 35 days 
1978 [66] 
Cell mediated immunity:       
0, 0.1, 0.2, 0.4, 0.8 
Broiler, 14–49  
-  ↓ DHST from 0.2 ppm  -  1985 [60] 
0.1, 0.2, 0.4, 0.5, 1.0 
Broiler, 14–49  
- 
↓DHST at 0.4 ppm 
AFB1 + AFB2 
DHST on AFB1 alone  1985 [59] 
1 
Broiler, 7–49  
-  ↓ DHST  -  2003 [61] 
0.3 
Leghorn, 1–42 
- 
↓ DHST at 30, 45,  
and 60 days age 
-  1988 [67] 
Abbrev.: ↓ reduction; ↑ increase; ? not specified; - data not relevant; DHST, delayed hypersensitivity 
skin test; IB, infectious bronchitis; IBD, infectious bursal disease; ND, Newcastle disease. 
The data presented in Table 5 are not the first observations of increase in humoral immune response 
during initial stages of exposure to low levels of AFB1. Similar results, i.e., an initial increase followed 
by a decrease in humoral immune response, have been documented in at least two previous reports. 
However, these effects of AFB1 were not discussed in any of these reports and thus had remained 
overlooked. For instance, Giambrone et al. [59] who conducted two separate experiments in 1985 on 
Hubbard broilers, noted a non-significant increasing trend in ND titers with increase in the AFB1 Toxins 2011, 3                                       
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content  of  ration  from zero  to 0.5 mg/kg in one  of these experiments.  Also, a higher (P < 0.05) 
response from fowl cholera vaccine was noted in the birds fed 0.5 mg AFB1/kg diet. In the other 
experiment, higher (P < 0.05) ND, and fowl cholera titers were noted in birds fed 0.1 mg, and 0.2 mg 
AFB1/kg diet, respectively. The increase in titers against ND and fowl cholera in birds fed on AFB1 
contaminated ration was not seen in the birds fed on rations containing mixtures of AFB1 and AFB2. In 
a latter study, these authors reported non-significantly higher titers against ND and fowl cholera in 
birds fed on 0.1 to 0.8 mg AFB1/kg rations as compared to the birds fed on control ration [60]. The 
underlying mechanisms for this temporary increase in humoral immune response are not known. As a 
matter of fact, the exact mechanisms of even immunosuppression during aflatoxicosis are not clearly 
understood in spite of 50 years of research on the mycotoxin. In this regard, Corrier [68], and Surai and 
Dvorska  [54]  have  reviewed  some  aspects  of  AFB1-induced  immunotoxicity.  A  brief  but 
comprehensive discussion on the subject can also be found in an article by Celik et al. [49]. It is a 
general observation that size of lymphoid organs is not normal in birds exposed to AFB1 (Table 2). In 
such  animals,  lymphoid  cell  depletion  in  thymus,  spleen,  and  bursa  of  Fabricius  has  been  
described [61]. Thus one explanation of immunotoxicity of AFB1, as also proposed by Azzam and 
Gabal [65,69], could be inhibition of antibody production through the toxin’s effects on lymphocytes 
leading to enhanced turnover of serum antibodies and consequently to decreased antibody half-life. 
Table 5. Effects of level and length of AFB1 exposure on ELISA titers against Newcastle 
disease and serum protein in Ross 308 broilers 
1. 
Item  2nd Week Exposure  4th Week Exposure  5th Week Exposure 
Titers against ND:       
0.07 mg AFB1/kg diet  33%  407%  −27% 
0.75 mg AFB1/kg diet  127% *  594%  −28% 
Serum protein:       
0.07 mg AFB1/kg diet  5%  −2%  2.6% 
0.75 mg AFB1/kg diet  −32% **  −32% *  −21% * 
Significant differences with regards to control with * at P < 0.05, ** at P < 0.01. Data presented as 
percentage  change  over  control. 
1  Experiment  conducted  in  2010  (author’s  unpublished  data). 
Statistical analysis by using ANOVA and LSD (n = 7/treatment). 
During earlier studies on effects of AFB1, Tung et al. [70] described the toxin-induced increase in 
lysosomal enzyme activity in liver and skeletal muscles of chicken. These authors postulated that this 
increase in lysosomal activity, besides other factors, could negatively affect tissue integrity during 
aflatoxicosis. In this regard, dietary AFB1 has been found by Çelik et al. [49] to result in degeneration 
of  follicle  associated  epithelium  (FAE)  in  bursa  of  Fabricius  and  destruction  of  thymic  cortex  in 
chicken. On the grounds of the report of Tung et al., it was therefore urged that any impaired function 
of FAE might result in serious deficiencies in both cellular and antibody responsiveness of the chicken 
immune system [49]. This is because FAE of bursal follicles play a crucial role in antigen presentation 
to the lymphoid cell population. Besides the effects on lymphocytes, non-specific effects of the toxin 
on protein synthesis through inhibition of RNA polymerase, lipid peroxidation, and liver injury are 
also  considered  to  result  in  reduced  immunoglobulin  production.  The  data  presented  in  Table  5 
however indicate modulation of serum protein and antibody titers in different directions. This indicates Toxins 2011, 3                                       
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that AFB1-induced modulation of humoral immunity in broilers may not be a result of the toxin’s  
non-specific effects on protein metabolism. 
5. Effects of Aflatoxin B1 on Gastrointestinal Tract 
Gastrointestinal tract is the main site where conversion and absorption of food components takes 
place. The host-derived physiological processes, the residing microorganisms, and healthy absorptive 
surfaces are all equally important to ensure normal nutrient supply. Gastrointestinal tract is the first 
organ coming into contact with mycotoxins of dietary origin and should be expected to be affected by 
AFB1 with greater potency as compared to other organs. However, this aspect of aflatoxicosis is the 
often neglected area of mycotoxin research and available literature is non-conclusive.  
5.1. Aflatoxin B1 and Gut Morphology 
Various studies documenting effects of AFB1 on weight and histological characteristics of different 
segments of GIT are summarized in Table 6. The weights of proventriculus, gizzard, and pancreas 
relative to body weight of broilers have not been reported to be affected at levels of AFB1 up to  
3.5 mg/kg diet [39,44,48]. However, at a dietary level of 4 mg AFB1/kg or higher, the relative weight 
of these organs has been noted to decrease by some authors [45,56], while increase by other [46]. 
However, Edrington et al. could not find any effect of 4 mg AFB1/kg diet on the relative weight of 
gizzard and pancreas [43]. 
Literature on the effects of AFB1 on histology of GIT is scanty and not conclusive. In this regard, 
the density of whole intestine (weight/length) has been reported to decrease after 3 weeks of dietary 
exposure to AFB1 at levels as low as 0.02 mg/kg [48] and 0.7 mg/kg [71]. As the width of muscularis 
tends of be relatively constant, the density of intestine could be a good indicator of unit absorptive 
area. On this variable, the effects of higher AFB1 dosage in broilers are not known. At higher levels of 
1 mg AFB1/kg diet, Kumar and Balachandran however noted catarrhal enteritis with lymphocytic or 
mononuclear  cell infiltrations in the  intestine of broilers fed on the toxin contaminated  ration  for  
4 weeks [72]. Contrary to these reports, no histopathological changes in duodenum, jejunum, cecum, 
and ileum could be noted by Ledoux et al. when male broilers were exposed to 4 mg AFB1/kg diet for  
3 weeks [46]. Similarly, breaking strength, size, and collagen content of large intestine was not found 
to be affected in broilers (male Cobb ×  Cobb; exposure age 1 to 21 days) exposed to 0, 0.6, 1.2, 2.5, 
5.0, and 10 mg AFB1/kg diet in the earlier report by Warren and Hamilton [73]. Lipid content of large 
intestine was decreased only at the highest level of AFB1 (10 mg/kg) in that report. 
From the aforementioned studies, it is difficult to draw a dose-effect relationship between AFB1 and 
histological changes in the GIT. This is because specific sections of GIT, studied variables, and length 
of exposure were different in the aforementioned studies. Furthermore, the type and specific line of 
chicken used in various studies may also affect the reaction of intestine towards chronic aflatoxicosis. 
This hypothesis is supported by the recent observations regarding aflatoxicosis in layers (Hyline W36; 
exposure age from 140 to 154 days) by Applegate et al. [74]. Contrary to the observations in broilers, 
these authors noted a linear increase in the crypt depth in distal jejunum with the increasing levels of 
AFB1 in the diet as 0, 0.6, 1.2, and 2.5 mg/kg, but no effect of the toxin on villus height and number of Toxins 2011, 3                                       
 
 
577 
goblet cells. However, the duration of exposure to AFB1 was short as compared with other studies and 
may not be long enough to provoke morphological changes in jejunum of layers. 
Table 6. Weight and histology of individual segments of gut in chicken during exposure to AFB1. 
AFB1 Level (ppm) 
Bird Type, Age (days) 
n * 
Characteristics of Gut  Year of Study 
and Reference  Effects  No Effects 
0.07, 0.7 
♂ Ross308, 7–29  
(7) 
↓ Density of duodenum  
and jejunum 
↑ Length of duodenum  
and jejunum 
Weight of proventriculus  
and gizzard  
2011 [71] 
0.02 
♂ Hybro, 21–49  
5  ↓ Density of intestine 
Gizzard weight; intestinal 
weight and length 
2010 [48] 
0.1 
♂ Ross308, 427–457  
4 
(3) 
-  Pancreas weight  2010 [57] 
0.3 
Broilers, 1–35  
12  -  Gizzard weight  2000 [39] 
1 
Broiler, 1–28  
2 
(5) 
Necrosis/fibrosis in crop  
and proventriculus. Catarrhal 
enteritis in intestine 
-  2009 [72] 
0.6, 1.2, 2.5 
♀ W36, 140–154  
8 
linear effect: ↑ crypt  
length in distal jejunum 
Number and density of 
goblet cell in jejunum 
2009 [74] 
3.5 
Broilers, 1–21  
6 
(4) 
-  Gizzard weight  1997 [44] 
4 
♂PetxHubb, 1–21  
6 
(3) 
- 
Gizzard and pancreas 
weight 
1997 [43] 
4 
♂ Broilers, 1–21  
5 
(3) 
↑ Proventriculus and  
pancreas weight 
Microscopic evaluation  
of pancreas and whole 
GIT 
1998 [46] 
5 
AA x Pet, 1–21  
6 
(2) 
↑ Gizzard and pancreas 
weight 
Proventriculus weight  1998 [56] 
5 
Broilers, 1–21  
6 
(2) 
↑ Proventriculus and  
pancreas weight 
-  1998 [45] 
0, 0.6, 1.2, 2.5, 5, 10 
♂CobbxCobb, 1–21  
4 
(10) 
- 
Breaking strength and  
size of large intestine 
1980 [73] 
*  Number  of  replicates.  The  figure  in  parenthesis  indicates  number  of  animals  per  replicate.  
AA, Arbor Acres; Hubb, Hubbard; Pet, Peterson; W36, Hyline W36. 
From the recent studies of Kana et al. [48], Yunus et al. [71], and Kumar and Balachandran [72] in 
broilers, it appears that the unit absorptive surface of small intestine would deteriorate during a chronic 
exposure to low levels of AFB1. However, broilers have been noted to compensate the reduced unit 
absorptive surface by increasing the length of small intestine in one study [71]. Such a reaction of 
intestinal tissues to low levels of AFB1, if also proven in future studies, would certainly add to the 
present understanding regarding intestinal adaptability to chronic AFB1 exposure. Toxins 2011, 3                                       
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5.2. Aflatoxin B1 and Active Transport of Nutrients 
After a thorough search of various databases only two reports could be found in which the issue of 
intestinal active transport of nutrients during aflatoxicosis was addressed. In this connection Ruff and 
Wyatt showed that 3 weeks feeding of 1.25 to 5 mg AFB1/kg diet has no effect on in vitro absorption 
of glucose and methionine in the intestine of broilers [75]. However, a high dose of 10 mg AFB1/kg 
diet, for more than 1 week, increased both the mediated and diffusion components of glucose and 
methionine absorption. Absorption of glucose and methionine was not affected in broilers exposed to 
these high amounts of AFB1 for only one week in the study of Ruff and Wyatt. In the second study 
which utilized murine in vitro model, acute exposure to AFB1 (5 µg/mL of buffer) was not found to 
affect glucose uptake in everted rat jejunum [76]. 
In some studies, active nutrient uptake was not addressed but movement of ions across intestinal 
epithelia and activity of ion transporters was studied. These studies may give some insight into the 
possible mechanisms of effects of AFB1 on active transport of nutrients including glucose absorption. 
This is because the active absorption of glucose through sodium glucose co-transporter (SGLT1) is 
influenced by intracellular levels of Na
+
 and movement of other ions across a cell. In this regard, 
Chotinski et al. [77] studied the effects of 7 weeks of dietary exposure to 0.25 and 0.6 mg AFB1/kg 
diet  on  activity  of  Mg
2+(Na
+/K
+)-ATP  in  small  intestinal  mucosa  of  broilers.  In  this  study,  
0.6 mg AFB1/kg diet was found to suppress the activity of Mg
2+(Na
+/K
+)-ATP in small intestinal 
mucosa.  Recently,  acute  AFB1  exposure  has  been  reported  to  evoke  acetylcholine-sensitive 
contractions in the rat ileum [78]. One effect of acetylcholine and other cholinergic secretagogues is to 
increase basolateral K
+ efflux and apical Cl
− secretion in epithelia [79]. During higher outgo of anions 
from epithelia, a lower absorption of Na
+ and consequently lower absorption of glucose is expected. In 
this regard in vitro AFB1 has been found to evoke cholinergic secretion of Cl
− and negatively affect 
glucose absorption in broiler’s jejunum [80]. However, these effects of acute exposure could not be 
established for a chronic exposure of broiler’s to low levels of AFB1 [71]. It therefore seems that 
intestinal tissues may adapt to an on-going dietary challenge to low levels of AFB1 as far as active 
transport of nutrients is concerned. 
5.3. Aflatoxin B1, and Digestibility and Activity of Digestive Enzymes 
Aflatoxin B1 is widely believed to result in malabsorption syndrome regarding macro nutrients and 
also in reduced activity of digestive enzymes [38,54]. However, many reports contrary to this notion 
are available. For instance, Nelson et al. did not find any effect of AFB1 (natural contamination of corn 
with  A.  flavus)  on  dry  matter  (DM),  and  amino  acid  digestibility,  and  energy  utilization  in  
chicken [81]. Applegate et al. did not find any effect of 0.6, 1.2, and 2.5 mg AFB1/kg diet on digestibility 
of DM and nitrogen (N) per hen/day [74]. At 0.6 and 1.2 mg AFB1/kg diet, the apparent metabolizable 
energy (AME) was however found to be reduced in their study. Regarding the activity of pancreatic 
enzymes, Mathur et al. found higher amylase and chymotrypsin activity, while lower lipase activity after 
exposure of Ross 308 female birds to 0.1 mg AFB1/kg diet (at 427 to 457 days age) [55]. The activity of 
trypsin in pancreas was not affected by AFB1 treatment. These results, except for reduction in lipase 
activity, are supported by earlier work of Richardson and Hamilton on layers [82]. These authors Toxins 2011, 3                                       
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reported that 4 mg AFB1/kg diet increases the activity of pancreatic chymotrypsin, amylase, and lipase. 
Pancreatic trypsin was not affected by AFB1 in their study and the noted changes in the pancreatic 
secretions were also not reflected in the lipid content of the feces. Contrary to these two reports, 
Osborne and Hamilton noted lower activity of pancreatic amylase, trypsin, lipase, RNase, and DNase 
when broilers were exposed to 1.25 and 2.5 mg AFB1/kg diet [83]. 
Regarding activity of intestinal enzymes, Mathur et al. in their aforementioned report found lower 
lipase activity in duodenum after exposure of Ross 308 female birds to 0.1 mg AFB1/kg diet [55]. 
These authors found that AFB1 at the tested low level had no effect on amylase and chymotrypsin 
activity in duodenum and jejunum, and lipase activity in jejunum. The activity of trypsin in duodenum, 
and  jejunum  was  also  not  affected  by  the  AFB1  treatment.  Contrary  to  the  case  of  broilers,  
Applegate et al. found the intestinal maltase activity to increase quadratically up to the doses of 1.2 mg 
AFB1 while decrease at 2.5 mg AFB1 with the exposure of layers (from 140 to 154 days age) to 0, 0.6, 
1.2, and 2.5 mg AFB1/kg diet [74]. These changes were however not found to affect digestibility and 
retention of DM and N. 
From the presented literature, it is impractical to draw any conclusions regarding effects of a certain 
level of AFB1 on digestive functionality in broilers. Some studies, in the past decade however indicate 
that the decreased nutrient utilization observed in those studies might be a factor of the effects of the 
toxin on systemic metabolism rather than an effect on digestive functionality [84,85]. This notion is 
also supported by the fact that apparent metabolizable energy of AFB1-contaminated rations was noted 
to be negatively affected by all the authors who included this variable in their studies and did not find 
any effect of the toxin on nutrient digestibility. More studies are no doubt needed in this direction. 
5.4. Aflatoxin B1 and Intestinal Innate Immunity 
The innate immune system of intestine plays a vital role in maintaining the integrity of the intestine 
and also participates with adaptive immune system in ensuring the subtle equilibrium between immune 
tolerance and immune response in the GIT [86]. Intestinal intraepithelial cells (IEC) in this regard 
produce a diversity of antimicrobial peptides and enzymes that protect intestinal mucosa and crypts 
against microbes. Some of these molecules also function in alarming the adaptive immune system. 
Contrary to many other mycotoxins, AFB1 has not been considered to date for possible effects on these 
peptides and  enzymes. Furthermore, the barrier function of  IEC during aflatoxicosis has not been 
subjected  to  extensive  research.  This  passive  barrier  is  formed  by  the  IECs  themselves,  the  tight 
junctions sealing the intercellular spaces, and the mucus secreted by them. This barrier provides a 
passive means to prevent most bacteria and antigens entering the body, and at the same time minimizes 
electrolyte and fluid loss into the intestinal lumen. Transepithelial electrical resistance (TEER) is an 
important indicator of barrier function of IEC. Limited data related with intestinal health suggests that 
AFB1 can only moderately affect TEER during acute  exposure to the toxin [80]. In the report of 
Warren and Hamilton, mentioned under Section 5.1, a 3 weeks administration of AFB1 at the levels of 
0, 0.6, 1.2, 2.5, 5.0, and 10 mg/kg diet to broiler chicks however did not affect the gross variable of 
breaking strength of large intestine [73]. 
In murine models, AFB1 has been found in some studies to result in morphologically damaged 
intestinal mucosal linings [87]), and in decreased cell proliferation [88]). In this regard, Watzl et al. Toxins 2011, 3                                       
 
 
580 
found AFB1 to induce genotoxicity (comet assay) in isolated rat jejunal epithelial cells. However, oral 
exposure of rats to moderate doses of AFB1 (100 µg/kg body weight once a week for 5 consecutive 
weeks), in the same study, was not found to induce DNA damage in jejunal epithelium [89]. Most 
recent  report in  this connection is of Garc a et  al., who reported that  AFB1 acts in  synergy  with 
fumonisins  in  affecting  intestinal  barrier  function  as  determined  by  cellular  proliferation,  cellular 
damage, and synthesis of IL-8 in porcine intestinal epithelial cell line [90]. Aflatoxin B1 alone was 
found in this report to only affect the morphological characteristics of the cells and not other variables. 
From reports on species other than chicken, moderate and indirect effects (secondary to systemic) of 
AFB1 on TEER of small intestine may be speculated. The practical significance of any such effect has 
been a subject of three different studies. In this connection, Rao et al. studied the clinical signs and gross 
lesions  caused  by  Eimeria  uzura  in  Japanese  quail  during  intercurrent  dietary  aflatoxicosis  [91,92].  
In these studies, no significant differences in the mucosal morphology of the intestine were evident 
histologically.  However,  these  authors  found  that  the  combination  of  E.  uzura  infection  and 
aflatoxicosis causes reduced packed cell volume and hemoglobin, weight loss, increased coccidian 
oocyst production,  and higher morbidity (60 vs. 8.3%) and mortality  (28.3 vs. 6.6 and 21.6%) as 
compared to the coccidia or toxin alone. It was concluded that aflatoxicosis may influence the course 
of coccidial infection due to additive effects. In an earlier study on broiler’s exposure to 2.5 μg AFB1 
and/or Eimeria acervulina, Ruff et al. also concluded that the birds exposed to combined treatment 
gain significantly less weight with greater plasma depigmentation (deduced from plasma β-carotene 
level), but without apparent differences in gross lesions in intestine caused by the coccidian [93]. 
5.5. Interaction of Aflatoxin B1 with Gut Microbes 
Since the 1940s various studies have shown antimicrobial potential of several mycotoxins [94–98]. 
Regarding  aflatoxins,  the  study  of  Burmeister  and  Hesseltine  in  1966  was  probably  the  first 
comprehensive study in which several microorganisms (329 spp.) were tested for their sensitivity against 
AFB1 [99]. Among the strains tested in that investigation, 12 species of genus Bacillus, a Streptomyces 
sp.  and  Clostridium  sporogenes  were  inhibited  when  various  levels  of  AFB1  (15–30  μg/mL)  were 
incorporated into the growth substrate. None of the yeast strains tested in the study was affected by 
AFB1 even at 40 μg/mL concentration. Bacillus megaterium and B. brevis were most susceptible to 
AFB1, and many of the subsequent studies demonstrated the extreme sensitivity of B. megaterium to 
AFB1 (as low as 1 μg AFB1/mL) [100–102]. Contrary to the study of Burmeister and Hesseltine, 
inhibitory effects of AFB1 on many fungal strains including A. flavus itself, A. awamori, Penicillium 
chrysogenum, and P. duclauxi were reported later [103]. Similarly, 10 ppm AFB1 was found to inhibit 
the enzyme activity of Mucor hiemalis [104]. In other contemporary studies A. niger, A. parasiticus, 
P. expansum,  Cladosporium  herbarum,  Rhizopus  nigricans,  Thamnidium  elegans,  and  Neurospora 
crassa were also identified as being sensitive to 50 to 100 μg AFB1/mL [105–108]. A comprehensive 
review of these studies has been presented earlier by Reiss [109]. In recent studies, AFB1 was found to 
selectively inhibit Streptococcus agalactiae, S. aureus, and Yersinia enterocolitica [110].  
Most of the earlier literature was dedicated to finding suitable bacterial test strains for mycotoxin 
bioassays. However, the biological methods for detection of aflatoxins were found to be of little use in 
the surveillance of the toxin [111]. Several E. coli, Salmonella typhimurium, and Bacillus strains on Toxins 2011, 3                                       
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the other hand have found uses as testers in genotoxic studies [112–116]. Other than the genotoxic 
effects, the toxic effects of aflatoxin on various microbes have been proposed to be as inhibition of  
oxygen [117] and inulin uptake [118], generation of oxygen radicals [119] and formaldehyde and its 
reaction products [120], and damage to cell membrane causing leakage of cell contents [118,121]. An 
interesting feature of these antimicrobial effects is that during continuous exposure to AFB1, some 
sensitive bacterial species (B. cereus, Proteus mirabilis) are able to survive the toxic effects to the 
extent  that  their  growth  is  enhanced  by  presence  of  the  mycotoxin  [122]  indicating  ability  to 
metabolize AFB1. 
In spite of the indicated antimicrobial potential of AFB1, data regarding effects of the toxin on gut 
microbial population and fermentation are scanty. Kubena et al. in this regard performed two, 10-days 
experiments  to  study  cecal  VFA’s  and  broiler  chick  susceptibility  to  Salmonella  typhimurium 
colonisation as affected by 2.5 and 7.5 mg aflatoxins/kg diet [123]. In one of these experiments no 
effects of aflatoxins were found on Salmonella colonization and on cecal VFA production. However, 
in the second experiment, both dietary levels of aflatoxins resulted in significant increase in total 
VFA’s at 5 days age. The lower aflatoxin dose (2.5 mg/kg diet) appeared to be more effective as it also 
resulted in significantly higher total VFA’s at 7 days age. 
Related to the issue of effects of AFB1 on gut microbes, interesting data were presented in an earlier 
study of Larsen et al. [124]. These authors studied the effect of AFB1 on susceptibility of hamsters to 
orally  administered  Mycobacterium  paratuberculosis.  In  the  negative  control  group,  the  bacillus 
passed  the  epithelial  barrier  of  the  intestine  and  infection  was  established  in  small  intestine  and 
mesentric lymph nodes. In the positive control and test groups, aflatoxin-treated hamsters grew slowly 
and showed signs of AFB1 toxicity. Interestingly, the addition of AFB1 to the rations did not increase 
the susceptibility of hamsters to M. paratuberculosis, rather it decreased susceptibility to the bacillus. 
Hamsters not treated with AFB1 and infected with M. paratuberculosis had higher intestinal bacterial 
counts than did infected hamsters that had been treated with AFB1. These results are substantiated by 
the  study  of  Abdelhamid  et  al.  who  found  that  effects  of  AFB1  on  rumen  fermentation  may  be  
like  antibiotics:  Affecting  the  harmful  flora  and  encouraging  the  rumen  microflora  as  noted  by  
slight  improvements  regarding  in  vitro  rumen  fermentation  of  wheat  straw  and  berseem  
(Trifolium alexandrinum) hay after dietary AFB1 exposure [125]. In this regard, fermentation patterns 
of Saccharomyces cerevisiae, and several Lactobacillus spp. have been noted to change under the 
influence of AFB1 [126,127]. Sutic and Banina in this regard reported that under the influence of 
AFB1, Lactobacillus casei, L. plantarum, and Streptococcus lactis, well known as not producing gas 
from glucose and other sugars, became heterofermentative and started producing significant amount of  
gas  [128].  However,  these  studies  do  not  warrant  any  positive  effects  of  AFB1  on  intestinal  
microbial population. 
6. Conclusions 
Recent literature documents the negative effects of those low dietary levels of aflatoxins which 
were  previously  thought  to  have  no  impact  on  broiler  performance.  Furthermore,  available  data 
indicate that both the level and the length of exposure influence the response of broilers towards 
chronic aflatoxin challenge. Therefore any attempt to establish dose-effect relationship between dietary Toxins 2011, 3                                       
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aflatoxin  level  and  broiler’s  performance  would  be  influenced  by  these  factors.  Scanty  data  also 
indicate that some variables including bird performance and humoral immunity might improve during 
initial phases of exposure to aflatoxin. 
In spite of 50 years of continuous research on aflatoxins, several areas of aflatoxicosis remain yet to 
be explored. These areas, as discussed in the present attempt, include comparative hepatic metabolism 
of aflatoxin, and response of gastrointestinal tract to the toxin. Literature available, regarding effects of 
the  toxin  on  gastrointestinal  tract,  is  particularly  non-conclusive.  However,  there  is  evidence  that 
gastrointestinal tract may adapt in some ways to a chronic aflatoxin challenge. As gastrointestinal tract 
is the first organ coming into contact with dietary aflatoxin challenge, its response toward the toxin 
may yield interesting data regarding tissue adaptability during chronic aflatoxicosis.  
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